当前位置: 首页 » 政策法规 » 国外法规 »DECISION (EU) 2016/598:根据欧洲议会和理事会条例(EC) No 258/97,批准扩大南极磷虾(磷虾)脂质提取物作为一种新型食品配料的使用范围(authorising an extension of use of lipid extract from Antarctic Krill (Euphausia superba) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council)

DECISION (EU) 2016/598:根据欧洲议会和理事会条例(EC) No 258/97,批准扩大南极磷虾(磷虾)脂质提取物作为一种新型食品配料的使用范围(authorising an extension of use of lipid extract from Antarctic Krill (Euphausia superba) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council)

扫描二维码 分享好友和朋友圈
放大字体  缩小字体 2016-04-27  来源:欧盟  浏览次数:435
核心提示:2016年4月19日,欧盟发布委员会实施条例(EU)2016/598,根据欧洲议会和理事会条例(EC)No 258/97,批准南极磷虾(磷虾)脂质提取物作为一种新型食品配料用于膳食补充剂
发布单位
欧盟委员会
欧盟委员会
发布文号 DECISION (EU) 2016/598
发布日期 2016-04-19 生效日期 暂无
有效性状态 废止日期 暂无
备注 2016年4月19日,欧盟发布委员会实施条例(EU)2016/598,根据欧洲议会和理事会条例(EC)No 258/97,批准南极磷虾(磷虾)脂质提取物作为一种新型食品配料用于膳食补充剂,其最大使用量如下:
1.普通人群3/天。2.孕期和哺乳期妇女450毫克/
 COMMISSION IMPLEMENTING DECISION (EU) 2016/598
of 14 April 2016
authorising an extension of use of lipid extract from Antarctic Krill (Euphausia superba) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
(Only the English text is authentic)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (1), and in particular Article 7 thereof,
Whereas:
(1)
Commission Decision 2009/752/EC (2) authorised, in accordance with Regulation (EC) No 258/97, the placing on the market of lipid extract from Antarctic Krill (Euphausia superba) as a novel food ingredient to be used in certain foods and foodstuffs.
(2)
On 11 December 2009, the company Aker BioMarine Antarctic AS notified the Commission about the intention to place on the market a lipid extract from Antarctic Krill (Euphausia superba) based on an opinion by the competent food assessment body of Finland on its substantial equivalence to a lipid extract from Antarctic Krill (Euphausia superba) authorised by Decision 2009/752/EC.
(3)
On 15 September 2014, the company Aker BioMarine Antarctic AS made a request to the competent authorities of Ireland for extension of uses of lipid extract from Antarctic Krill (Euphausia superba) as a novel food ingredient.
(4)
On 23 December 2014, the competent food assessment body of Ireland issued its initial assessment report. In that report, it came to the conclusion that the extension of uses of lipid extract from Antarctic Krill (Euphausia superba) meets the criteria for novel food set out in Article 3(1) of Regulation (EC) No 258/97.
(5)
On 22 January 2015, the Commission forwarded the initial assessment report to the other Member States.
(6)
Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97. The applicant consequently modified the request concerning the food categories proposed. This change and additional explanations by the applicant alleviated the concerns to the satisfaction of the Member States and the Commission.
(7)
Directive 2002/46/EC of the European Parliament and of the Council (3) lays down requirements for food supplements. The use of lipid extract from Antarctic Krill (Euphausia superba) should be authorised without prejudice to the requirements of that legislation.
(8)
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
Article 1
Lipid extract from Antarctic Krill (Euphausia superba) as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to the specific provisions of Directive 2002/46/EC.
Article 2
The designation of a lipid extract from Antarctic Krill (Euphausia superba) authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘lipid extract from the crustacean Antarctic Krill (Euphausia superba)’.
Article 3
This Decision is addressed to Aker BioMarine Antarctic AS, PO Box 496, NO-1327 Lysaker, Norway.
Done at Brussels, 14 April 2016.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission

ANNEX I

Specification of a lipid extract from Antarctic Krill (Euphausia superba)

Description: To produce lipid extract from Antarctic Krill (Euphausia superba), milled Antarctic Krill is subjected to an extraction with ethanol. Proteins and krill material are removed from the lipid extract by filtration. The ethanol and residual water are removed by evaporation.

Test

Specification

Saponification value

Not more than 185 mg KOH/g

Peroxide value (PV)

Not more than 2 meq O2/kg oil

Moisture and volatiles

Not more than 0,6(1)

Phospholipids

Not less than 35 % w/w

Trans-fatty acids

Not more than 1 % w/w

EPA (eicosapentaenoic acid)

Not less than 15 % of total fatty acids

DHA (docosahexaenoic acid)

Not less than 7 % of total fatty acids


(1)  Expressed as water activity at 25 °C.


ANNEX II

Authorised uses of a lipid extract from Antarctic Krill (Euphausia superba)

Food category

Maximum content of combined DHA and EPA

Food supplements as defined in Directive 2002/46/EC.

3 g per day for general population

450 mg per day for pregnant and lactating women

Note: All food products containing DHA- and EPA-rich oil from Antarctic Krill should demonstrate oxidative stability by appropriate and recognised national/international test methodology (e.g. AOAC).

 
将全文内容保存为word文档
食品伙伴网提供标准法规管理咨询服务,详情请咨询
邮箱:foodinfo@foodmate.net
QQ:2891238009
食品标法圈
实时把握食品标法动态
请扫码关注食品标法圈

声明:

① 凡本网所有原始/编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”。
② 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
※ 邮箱:law#foodmate.net(发邮件时请将#换成@) QQ:139307733

 
 
[ 政策法规搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 [ 关闭窗口 ]

 
0条 [查看全部]  相关评论

 
 
推荐国外法规
点击排行

法规中心  关于我们  广告业务  联系我们  信息服务